Patch-Type Wearable EEG Sleep Monitoring System

[INQ. NO. 2604E03] Slowave Inc. is a digital neuro-healthcare company that supports clinical decision-making through patch-type wearable electroencephalogram (EEG) sensor technology and advanced signal analysis algorithms.
Slowave has independently developed lightweight, wireless wearable EEG devices and precision signal processing technology, and continues to conduct research and development aimed at acquiring quantitative brain-signal data applicable to various neuropsychiatric conditions, including sleep disorders, delirium, and ADHD.

Slowave is further advancing its brain-signal analysis capabilities into clinically applicable diagnostic support systems. In the future, the company plans to integrate neuromodulation technologies to link analysis and treatment, expanding into precision neuro-medicine systems. Through this approach, Slowave aims to grow as a neurotech company contributing to the establishment of data-driven neurological disease-management environments.
Slowave has completed international CB certification and GMP certification for its proprietary patch-type wearable EEG hardware, securing medical device–level technical reliability and manufacturing quality-management standards. Based on this foundation, the company has commercialized its lightweight, wireless brainwave monitoring system, SLOWAVE 1.0 ― providing quantitative EEG data that clinicians can reference during patient consultations and expanding its potential for clinical application.

Slowave is also engaged in international research collaboration. Slowave is conducting joint research on EEG-based delirium analysis with the University of Michigan Medical School in the United States and is expanding its clinical research network in the U.S. market. In addition, the company plans to participate in the SLEEP 2026 conference and exhibition to be held in Baltimore, USA ― in order to validate its technology in North America and broaden global partnerships.
‘SLOWAVE 1.0’ is a Class II medical device certified by Korea’s Ministry of Food and Drug Safety (MFDS). It is a wireless, wearable EEG-based sleep monitoring system developed to complement the limitations of conventional hospital-based testing environments. By applying a patch-type electrode structure, it reduces the inconvenience of multi-channel electrode attachment and dependence on large diagnostic equipment. Once prescribed, patients can conduct sleep measurements at home or in other convenient environments, and clinicians review the analyzed results during consultations. This model enhances the traditional single-session, hospital-based testing structure by enabling repeated and continuous brainwave monitoring.

Notably, Slowave utilizes its proprietary Phase Information Analysis (PIA) algorithm to perform precise EEG signal analysis. The system aims to provide quantitative data applicable not only to sleep disorder evaluation but also to neuropsychiatric conditions such as delirium and ADHD.
Slowave has identified the United States and Japan as its primary target markets. The United States is experiencing rapid growth in digital health and neurotechnology sectors, with increasing demand for data-driven assessment of sleep disorders and neuropsychiatric conditions. Building on its research collaboration with the University of Michigan Medical School, Slowave plans to expand partnerships with major university hospitals and sleep medicine institutions for joint research and clinical applications.
Japan, a country facing rapid population aging, is also seeing increased demand for delirium and sleep disorder management. Slowave plans to secure clinical data through joint research with local university hospitals and research institutions and pursue market entry in collaboration with Japanese medical device companies.
As part of its U.S. expansion strategy, Slowave plans to participate in SLEEP 2026 and HLTH exhibitions to strengthen its network with sleep medicine researchers and clinicians, while exploring partnership opportunities with global digital health companies and investors. Through a phased global partnership strategy, the company aims to expand its presence in the digital neuro-healthcare sector.

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods